Upstream Bio logo

Upstream Bio

Waltham, MA

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. They are clinical-stage monoclonal antibodies that inhibit the TSLP receptor, a validated target located upstream of various signaling cascades that influence a range of immune cells that are important in common and unusual illnesses.

upstreambio.com

Company Details

Founded

2021

Employees

Between 20 - 50 employees

Raised

$408,000,000

Headquarters Location

Waltham, MA

Public

No

Acquired

No

CEO

Rand SutherlandRand Sutherland

Founders

Eran Perry
Eran Perry
Oren Becker
Oren Becker

Company Collections

These are collections Upstream Bio is a part of. Click on the collection name to view similar companies.